RAC 4.01% $1.68 race oncology ltd

Ann: RC220 Peripheral Infusion Safety Confirmed, page-25

  1. 420 Posts.
    lightbulb Created with Sketch. 204
    @Davisite Is the process that helped give RC220 its new dissolubility transferable to other drugs that have had other precipitation and phlebitis issues? Have RAC and their collaborators stumbled onto another potential income stream?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.